Iwama, E., Okamoto, I., Harada, T., Takayama, K., & Nakanishi, Y. (2014). Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer. Dove Medical Press.

Iwama, Eiji, Isamu Okamoto, Taishi Harada, Koichi Takayama, e Yoichi Nakanishi. Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-positive Lung Cancer. Dove Medical Press, 2014.

Iwama, Eiji, et al. Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-positive Lung Cancer. Dove Medical Press, 2014.